Hemodynamic tolerance of intravascular contrast agents for magnetic resonance imaging

Investigative Radiology

Volumn 32, Issue 12, 1997, Pages 755-762

  Knollmann, Friedrich D ^a   Sorge, Robert ^a   Mühler, Andreas ^b   Mäurer, Jürgen ^a   Muschick, Peter ^b   Böck, Johannes C ^a   Felix, Roland ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Contrast agents; Hemodynamics; Magnetic resonance imaging; Side effects

Indexed keywords

BIS(4 NITROBENZYL)GADOLINIUM DIETHYLENETRIAMINE PENTAACETIC ACID; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE; GADOLINIUM PENTETATE POLYLYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG TOLERANCE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RATE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0031450769     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199712000-00006     Document Type: Article

References (22)

1. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992;183:1-11.
2. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, Press WR, Weinmann HJ. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol 1991;26:1035-1040.
3. Schmiedl U, Ogan M, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: Biodistribution and imaging studies. Radiology 1987; 162:205-210.
4. Wang SC, MG Wikstrom, DL White, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues. Radiology 1990;175:483-488.
5. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: Preliminary studies in whole-blood phantom and in animals. AJR 1994;162:209-213.
6. Donahue KM, RM Weisskoff, DJ Parmelee, et al. Evaluation of tumor cellular volume fraction and interstitial albumin concentration using Gd-DTPA and a novel albumin-binding contrast agent. Proceedings of the Society of Magnetic Resonance, Second Meeting, August 6-12, 1994, San Francisco, CA, Vol. 2: 926).
7. Stark DD, Weissleder R, Elizondo C, et al. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver. Radiology 1988;168:297-301.
8. Mühler A, Saeed AM, Brasch RC, Higgins CB. Hemodynamic effects of bolus injection of gadodiamid e injection and gadopentate dimeglumine as contrast media at MR imaging in rats. Radiology 1992;183:523-528.
9. Higgins CB. Contrast media in the cardiovascular system. In: Sovak M, ed. Handbook of experimental pharmacology. New York: Springer, 1984:193-251.
10. Chahine RA, Raizner AE. The mechanism of hypotension following angiography. Invest Radiol 1976;11:472-478.
11. Morettin LB, Zhan X, Sant' Ambrogio FB, Sant' Ambrogio G. Cardiorespiratory responses elicited by right atrial injections of iodinated contrast media. Invest Radiol 1994;29:201-209.
12. Sullivan ME, Goldstein HA, Sansone KJ, Stoner SA, Holyoak WL, Wiggins JR. Hemodynamic effects of Gd-DTPA administered via rapid bolus or slow infusion: A study in dogs. Am J Neuroradiol 1990;11:537-540.
13. Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Safety and tolerance after intravenous administration of 0.2 mmol/kg Gd-DTPA. Invest Radiol 1991;26:S221-S223.
14. Niendorf HP, Haustein J, Cornelius I, Alhassan A, Clauß W. Safety of gadolinium-DTPA: Extended clinical experience. Magn Reson Med 1991;22:222-228.
15. Saeed M, Wendland MF, Masui T, et al. Myocardial infarction: Assessment with an intravascular MR contrast medium. Radiology 1991;180:153-160.
16. Van Hecke P, Marchai G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991;9:313-321.
17. Szolar DH, Saeed M, Flueckinger F, et al. Effects of iopromide on vasoactive peptides and allergy-mediated substances in healthy volunteers. Invest Radiol 1995;30:144-149.
18. Heyman SH, Clark BA, Cantley L, et al. Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 1993;28:313-318.
19. Grainger RG. Osmolality and osmolality-related side effects. In: Felix R, Fischer HW, Kormano M, et al, eds. Contrast media from the past to the future. Stuttgart: Thieme, 1987:25-32.
20. Karstoft J, Baath L, Jansen I, Edvinson L. Vasoconstriction of isolated ateries induced by angiographic contrast media. Acta Radiol 1995;36:312-316.
21. Pedersen HK. Electrolyte addition to nonionic contrast media. Acta Radiol 1996;37(Suppl 405):1-31.
22. Mühler A, Saeed M, Brasch RC, Higgins CB. Amelioration of cardiodepressive effects of gadopentate dimeglumine with addition of ionic calcium. Radiology 1992;184:159-164